|
Session 134
Poster Abstracts
Complications in Resource-limited Settings
Wednesday, 1-4 pm
Room: Hall B |
| 843 |
Clinical Features Associated with Lactic Acidosis in Malawi
Cecelia Kanyama*1, D Gomes2, E Katengeza1, N Saukila1, H Tweya3, G Joaki1, R Weigel3, M Hosseinipour1,2, and Lighthouse Group
1Univ of North Carolina Project, Lilongwe, Malawi; 2Univ of North Carolina at Chapel Hill, US; and 3Lighthouse Clin, Lilongwe, Malawi |
| 844 |
Low-dose Erythropoietin in the Management of HIV-related Anemia in Uganda
F Ssali1, J Kayiwa1, T Otim1, M Ssemmanda1, and Eugene Kinyanda*2
1Joint Clin Res Ctr, Kampala, Uganda and 2Med Res Council, Entebbe, Uganda |
| 845 |
Cause-specific Mortality and Contribution of Immune Reconstitution Inflammatory Syndrome during the First 2 Years of ART in Uganda
A Kambugu1, Barbara Castelnuovo*1, A Kiragga1, K Kigonya1, M Kamya2, and P Easterbrook1
1Infectious Diseases Inst, Kampala, Uganda and 2Makerere Univ, Kampala, Uganda |
| 846a |
Evaluation of Expert Opinion vs 2 Case Definitions of Immune Reconstitution Inflammatory Syndrome in a South African Cohort
L Haddow1,2, Yunus Moosa*1, N Khanyile1, Q Zulu1, N Sithole1, F Ibrahim2, and P Easterbrook2
1Univ of KwaZulu Natal, Durban, South Africa and 2King`s Coll London, UK |
| 846b |
Does Cotrimoxazole Prophylaxis Improve Outcomes after ART Initiation in HIV-infected African Adults: A Causal Analysis Using Marginal Structural Models
Ann Sarah Walker*1, D Ford1, F Ssali2, P Munderi3, A Reid4, A Kambugu5, C Gilks6, A Babiker1, and the DART Trial Team
1Med Res Council Clinical Trials Unit, London, UK; 2Joint Clin Res Ctr, Kampala, Uganda; 3Med Res Council/Uganda Virus Res Inst Prgm on AIDS, Entebbe, Uganda; 4Univ of Zimbabwe, Harare; 5Infectious Diseases Inst, Mulago, Uganda; and 6Imperial Coll, London, UK |
|
